Abacten Powder for Suspension

About Abacten 200 mg/5 ml Powder for Suspension

Abacten is a powder for suspension made by Arges Life Science Limited, containing azithromycin dihydrate at 200 mg/5 ml. It is a macrolide antibiotic prescribed for certain bacterial infections.

There are 90 brands of Azithromycin Dihydrate listed in Bangladesh. 80 of them have a lower unit price than Abacten. The lowest listed price is Azithrogen 500 mg Tablet at ৳ 15.00 per unit.

What is Abacten 200 mg/5 ml Powder for Suspension?

Abacten, from Arges Life Science Limited, is a powder for suspension that contains azithromycin dihydrate at a strength of 200 mg/5 ml. It belongs to the macrolide group of antibiotics. Doctors prescribe it for certain bacterial infections of the lower and upper respiratory tract, ear, skin and soft tissues. The powder is mixed into a liquid suspension before use. The doctor or pharmacist will explain how to prepare it and how long to continue it. Do not use it for viral illnesses such as the common cold, because it does not work against viruses.

Uses of Abacten

Abacten is used to treat certain bacterial infections caused by organisms that are sensitive to azithromycin. These include infections of the lower respiratory tract, such as bronchitis and pneumonia, and of the upper respiratory tract, such as sinusitis and throat infections. It is also used for middle ear infections and for skin and soft tissue infections. In some sexually transmitted infections, it may be prescribed. The doctor decides whether it is suitable for a particular infection.

How to use Abacten

Abacten is supplied as a powder that must be made up into a suspension. The doctor or pharmacist will explain how to prepare and measure it. Always follow their instructions. It is usually taken by mouth, and absorption may be better on an empty stomach. The doctor decides the dose and how many days it should be taken. Complete the full course even if symptoms improve early. Do not share it with anyone else or save leftover suspension for later use.

Side effects of Abacten

Abacten is generally well tolerated, but some people may notice nausea, vomiting, stomach pain or cramps, wind, diarrhoea, headache, dizziness or skin rashes. These effects are usually reversible when the medicine is stopped. If you develop a severe rash, swelling, or any worrying symptom, contact your doctor promptly. Your doctor can advise whether to stop the medicine. Do not start any other medicine without asking your doctor or pharmacist first.

Safety and precautions

Tell your doctor or pharmacist before starting Abacten if you are allergic to azithromycin, any other macrolide antibiotic, or any ingredient in the suspension. It should not be used by people with liver disease, or together with ergot derivatives. Use during pregnancy only if your doctor advises it, and ask for advice if you are breastfeeding. Caution is advised if you take digoxin or cyclosporine. Watch for signs of a new infection, including fungal infections, while taking it. Ask your doctor or pharmacist first about any concerns.

Frequently asked questions

What is Abacten used for and what kind of medicine is it?

Abacten is a macrolide antibiotic. It is prescribed for certain bacterial infections of the respiratory tract, ear, skin and soft tissues, and some sexually transmitted infections. It does not treat viral infections such as colds. Your doctor will decide if it is right for you.

How should I store Abacten?

Keep the powder and any prepared suspension in a dry place away from light and heat. Keep it out of the reach of children. Ask your pharmacist how long the prepared suspension can be kept and whether it should be refrigerated.

Who should avoid Abacten or ask the doctor first?

Do not use it if you are allergic to azithromycin or other macrolide antibiotics, have liver disease, or take ergot derivatives. Ask your doctor first if you are pregnant or breastfeeding, or take digoxin or cyclosporine. Tell your pharmacist about all your medicines.

What is the price of Abacten?

The listed price is ৳ 130.00.

Also available as

500 mg (Tablet)

Indications

Abacten is indicated for infections (caused by susceptible organisms) in lower respiratory tract infections including bronchitis and pneumonia, in upper respiratory tract infections including sinusitis and pharyngitis/tonsillitis, in otitis media, and in skin and soft tissue infections. In sexually transmitted diseases in men and women, Abacten is indicated in the treatment of non-gonococcal urethritis and cervicitis due to Chlamydia trachomatis.

Pharmacology

Azithromycin is acid-stable and can therefore be taken orally with no need of protection from gastric acids. It is readily absorbed; its absorption is greater on an empty stomach. Time to peak concentration in adults is 2.1 to 3.2 hours for oral dosage forms. Due to the high concentration in phagocytes, azithromycin is actively transported to the site of infection. During active phagocytosis, large concentrations of azithromycin are released. The concentration of azithromycin in the tissues can be over 50 times higher than in plasma. This is due to ion trapping and the high lipid solubility.

Azithromycin's half-life allows a large single dose to be administered and yet maintain bacteriostatic levels in the infected tissue for several days. Following a single 500 mg dose, plasma concentrations of azithromycin declined in a polyphasic pattern with a mean apparent plasma clearance of 630 mL/min and a terminal elimination half life of 68 hours. The prolonged terminal half-life is thought to be due to extensive uptake and subsequent release of drug from tissues. Biliary excretion of azithromycin, predominantly unchanged, is a major route of elimination. Over the course of a week, approximately 6% of the administered dose appears as unchanged drug in urine.

Microbiology: Azithromycin acts by binding to the 50S ribosomal subunit of susceptible microorganisms and, thus, interfering with microbial protein synthesis. Nucleic acid synthesis is not affected. Azithromycin has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections:
  • Aerobic and facultative gram-positive microorganisms: Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes
  • Aerobic and facultative gram-negative microorganisms: Haemophilus ducreyi, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae
  • Other microorganisms: Chlamydia pneumoniae, Chlamydia trachomatis , Mycoplasma pneumoniae , Betalactamase production should have no effect on azithromycin activity.
  • Aerobic and facultative gram-positive microorganisms: Streptococci (Groups C,F,G), Viridans group streptococci
  • Aerobic and facultative gram-negative microorganisms: Bordetella pertussis, Legionella pneumophila
  • Anaerobic microorganisms: Peptostreptococcus species, Prevotella bivia

Dosage & Administration

Oral-
Adult: 500 mg once daily orally for 3 days or 500 mg once on day 1, then 250 mg once on days 2-5 for 4 days. For sexually transmitted diseases caused by Chlamydia trachomatis in adults, the dose is 1 gm given as a single dose or 500 mg once on day 1, followed by 250 mg once daily for next 2 days may also be given.

Children:
  • 10 mg/kg body weight once daily for 3 days for child over 6 months
  • 200 mg (1 teaspoonful) for 3 days if body weight is 15-25 kg
  • 300 mg (1½ teaspoonfuls) for 3 days if body weight is 26-35 kg; 400 mg (2 teaspoonfuls) for 3 days if body weight is 36-45 kg.
  • In typhoid fever, 500 mg (2½ teaspoonfuls) once daily for 7-10 days is given.

Azithromycin Injection (For IV Infusion only)
: The recommended dose of Azithromycin for injection for the treatment of adult patients with community-acquired pneumonia due to the indicated organisms is:
  • 500 mg as a single daily dose by the intravenous route for at least two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 500 mg, administered as two 250-mg tablets to complete a 7 to 10-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response.
  • The recommended dose of Azithromycin for the treatment of adult patients with pelvic inflammatory disease due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for one or two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 250 mg to complete a 7-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response. If anaerobic microorganisms are suspected of contributing to the infection, an antimicrobial agent with anaerobic activity should be administered in combination with Azithromycin.
  • Safety and effectiveness of azithromycin for injection in children or adolescents under 16 years have not been established.

Interaction

Antacid: In patients receiving azithromycin and antacids, azithromycin should be taken at least 1 hour before or 2 hours after the antacid. Carbamazepine: In a pharmacokinetic interaction study in healthy volunteers, no significant effect was observed on the plasma levels of carbamazepine or its active metabolite.

Cyclosporin: Some of the related macrolide antibiotics interfere with the metabolism of cyclosporin. In the absence of conclusive data from pharmacokinetic studies or clinical data investigating potential interactions between azithromycin and cyclosporine, caution should be exercised before co-administration of these two drugs. If coadministrations is necessary, cyclosporin levels should be monitored and the dose adjusted accordingly.

Digoxin: Some of the macrolide antibiotics have been reported to impair the metabolism of digoxin (in the gut) in some patients. Therefore, in patients receiving concomitant azithromycin and digoxin the possibility of raised digoxin levels should be borne in mind and digoxin levels monitored.

Ergot derivatives: Because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administered.

Methylprednisolone: In a pharmacokinetic interaction study in healthy volunteers, azithromycin had no significant effect on the pharmacokinetics of methylprednisolone.

Theophylline: There is no evidence of any pharmacokinetic interaction when azithromycin and theophylline are co-administered to healthy volunteers. In general, however, theophylline levels should be monitored.

Warfarin: In a pharmacodynamic interaction study, azithromycin did not alter the anticoagulant effect of a single 15 mg dose of warfarin administered to healthy volunteers. Abacten and warfarin may be co-administered, but monitoring of the prothrombin time should be continued as routinely performed.

Terfenadine: Abacten did not affect the pharmacokinetics of terfenadine administered at the recommended dose of 60 mg every 12 hours. Addition of azithromycin did not result in any significant changes in cardiac repolarisation (QTc interval) measured during the steady state dosing of terfenadine.

Contraindications

Azithromycin Dihydrate is contraindicated in patients hypersensitive to Azithromycin or any other macrolide antibiotic. Co-administration of ergot derivatives and Azithromycin is contraindicated. Azithromycin is contraindicated in patients with hepatic diseases.

Side Effects

Abacten is well tolerated with a low incidence of side-effects. Most side-effects observed were mild to moderate in severity. The majority of side-effects were gastrointestinal in origin with nauseas, abdominal discomfort (pain/cramps), vomiting, flatulence, diarrhoea and loose stools being occasionally observed. Allergic reactions such as rash or photosensitivity have occurred and there have also been rare reports of serious hypersensitivity reactions. Reversible elevations in liver transaminases have been seen with a frequency similar to the comparative macrolides and penicillins used in clinical trials. Rarely, cases of cholestatic jaundice have been observed. Transient mild reductions in neutrofil counts have occasionally been observed in clinical trials, although a causal relationship to azithromycin has not been established. Hearing impairment: In investigational studies where higher doses were used for prolonged periods of time, reversible hearing impairment was seen in some patients.

Pregnancy & Lactation

Pregnancy Category of Azithromycin Dihydrate is B. Animal reproduction studies have demonstrated that Azithromycin has no evidence of harm to the fetus. There are no adequate and well controlled studies in pregnant women. Since animal reproduction studies are not always predictive of human response, Azithromycin should be used during pregnancy only if adequate alternatives are not available. It is not known whether Azithromycin is secreted in breast milk. So, caution should be exercised when Azithromycin is administered to nursing women.

Precautions & Warnings

As with erythromycin and other macrolides, rare serious allergic reactions, including angioneurotic oedema and anaphylaxis, has been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a long period of observation and treatment.

Overdose Effects

There is no data on overdosage with Abacten. Typical symptoms of overdosage with macrolide antibiotics include hearing loss, severe nausea, vomiting and diarrhoea. Gastric lavage and general supportive measures are indicated.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Azithromycin Dihydrate

Other brands with the same generic name, cheapest first.

See all 90 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.